HAEMATO AG (HAM:HAEK) Operating Cash Flow per Share : €2.17 (TTM As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is HAEMATO AG Operating Cash Flow per Share?

HAEMATO AG's operating cash flow per share for the six months ended in Jun. 2023 was €0.21. HAEMATO AG's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was €2.17.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for HAEMATO AG's Operating Cash Flow per Share or its related term are showing as below:

HAM:HAEK's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 5.8
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

HAEMATO AG Operating Cash Flow per Share Historical Data

The historical data trend for HAEMATO AG's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Operating Cash Flow per Share Chart

HAEMATO AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.25

-1.21

6.14

2.76

3.77

HAEMATO AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.11	2.87	1.76	1.96	0.21

Competitive Comparison of HAEMATO AG's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HAEMATO AG's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's Price-to-Operating-Cash-Flow falls into.

HAEMATO AG Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

HAEMATO AG's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	19.729	/	5.229
	=	3.77

HAEMATO AG's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	1.095	/	5.184
	=	0.21

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.17

HAEMATO AG Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

HAEMATO AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (HAM:HAEK) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lilienthalstrasse 5c, Schonefeld, DEU, D-12529

Website

https://www.haemato.ag

HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG Headlines

No Headlines